iiinova — where your digital self keeps evolving

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 22/08/2025

Founder’s Checklist: 5 Things to Post This Month Not sure what to post? Try this: • Milestone update • Personal lesson • Industry take • Team spotlight • Science explainer That’s your starter kit. #FounderTips #Biotech #LifeSciences

030

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 22/08/2025

Bluesky Engagement & Science Communication Less noise. More curiosity. That’s Bluesky. Founders here can have real convos about science, policy, and innovation, without fighting the algorithm. #ScienceComms #Biotech #Bluesky

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 21/08/2025

Breaking Down Regulatory Wins IND clearance? Great. But don’t just post the acronym. Explain it: what happened, why it matters, and what’s next. That’s how you pull people in. #Biotech #Regulatory #ScienceComms

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 21/08/2025

Why Bluesky is Perfect for Life Sciences Thought Leadership? Small platform = big chance. On Bluesky, your insights aren’t buried. Share industry takes, R&D lessons, and founder thoughts now. Shape the convo early. #Biotech #LifeSciences #ThoughtLeadership

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 20/08/2025

Funding News Isn’t Enough. “We raised $10M” gets a like. “We raised $10M to make treatments faster for patients” gets remembered. Funding is a story. Make people care. #BiotechFunding #Startups #LifeSciences

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 20/08/2025

What Bluesky Teaches Founders About Trust? Trust is built when you share wins and lessons. Don’t just post polished updates. Show the pivots, the struggles, the reality. That’s what sticks here. #FounderJourney #Biotech #Transparency

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 19/08/2025

Way to Make Complex Science Engaging Try this: ❌ “85% efficacy in murine models.” ✅ “Strong results in mice bring us closer to patient trials.” Clear beats clever. Every time. #ScienceComms #BiotechStartups #LifeSciences

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 19/08/2025

How to Share Clinical Milestones on Bluesky “Phase 1 complete” is boring. Tell a story: why it matters for patients, what’s next for your team, and why the field should care. Milestones are stories, not bullet points. #ClinicalTrials #Biotech #ScienceComms

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 18/08/2025

Bluesky vs LinkedIn: Where Should Founders Focus? LinkedIn = reach & investors. Bluesky = early adopters & authentic convos. Smart founders play both. Build trust here, visibility there. #StartupStrategy #BiotechFounders #Bluesky

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 18/08/2025

Why Founders Struggle with Translating Science to Social Media? Your research won’t reach people if it reads like a paper. Strip out the jargon. Clarity wins attention, not complexity. On Bluesky, founders who simplify win. #LifeSciences #ScienceComms #Biotech

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 08/08/2025

3 questions to ask before every post: - Will this teach my audience something new? - Could this spark a comment or DM? - Does this show my thinking clearly? If yes to all three, it’s a lead magnet.

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 08/08/2025

Old authority: Job titles and long bios. Polished but distant branding. Announcements only. New authority: Consistent public thinking. Sharing progress as it happens. Showing, not telling. Experts teach. Authorities demonstrate. #Biotech

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 07/08/2025

5 subtle CTAs for Bluesky posts: ↳ “Ask me how we solved this” ↳ “DM if this is your challenge too” ↳ “Would love to compare notes” ↳ “Curious if anyone else has tried this” ↳ “If you’re working on X, let’s talk” #LifeSciences

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 07/08/2025

Want to turn comments into leads? ✅ Answer industry questions directly. ✅ Share small, specific examples. ✅ Ask follow-up questions that spark DM chats. 👉 Leads start in public, then move to private.

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 06/08/2025

Leads don’t appear out of nowhere. On Bluesky, they come from visibility. Share your thinking, your challenges, and your niche expertise. The more people see your mind at work, the more likely they’ll trust you enough to start a conversation. #biotechnetworking

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 06/08/2025

3 mistakes life sciences founders make on Bluesky: ❌ Posting company updates only. ❌ Ignoring niche conversations. ❌ Treating it like LinkedIn 2.0 The fix? Show up as a scientist first, founder second. People follow expertise, not press releases. #StartupTips

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 05/08/2025

Old lead generation: Endless LinkedIn connection requests. Cold emails that never get opened. Generic newsletters. New lead generation: Posting useful insights on Bluesky. Answering niche questions in real time. Attracting inbound interest naturally. Leads find you when you stop chasing. #Biotech

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 05/08/2025

5 types of posts that generate leads for life sciences founders on Bluesky: - Break down recent trial data. - Explain a complex concept in 2 sentences. - Spotlight an industry partner - Share lessons from a failed experiment. - Predict a small but likely market shift. #LifeSciences

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 04/08/2025

Want to generate leads on Bluesky? ✅ Share niche insights your prospects rarely see. ✅ Comment with real expertise, not sales pitches. ✅ Join industry conversations early. Leads follow expertise faster than any cold DM. #leadgeneration #biotech #founders

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 04/08/2025

Most founders chase leads on LinkedIn because that’s where “everyone” is. But attention is noisy there. On Bluesky, your ideal partners, investors, and early adopters are easier to spot. A focused community is often worth more than a crowded one. #lifesciences #biotechfounders #earlyadopters

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 01/08/2025

Imagine pitching your company without any slides. Just story, relevance, clarity. Could you do it? #pitchpractice #foundermindset #biotechclarity

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 01/08/2025

You don’t need more likes. You need more people DMing you saying: “That post made me think.” Optimise for impact, not applause. #contentstrategy #biotechfounders #socialselling

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 31/07/2025

Founders who wait for 'traction' to start posting will miss the people who could’ve helped build it. Visibility is a growth lever. #lifesciencemarketing #earlystagebiotech #foundertips

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 31/07/2025

Biotech isn’t boring. But the way most founders explain it is. If your post wouldn’t make a curious 16-year-old stop scrolling, try again. #biotechedge #founderbranding #communicationskill

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 30/07/2025

Your target audience doesn’t care about your PhD. They care if you can solve their $10M problem. Talk to their priorities, not your credentials. #lifesciencebiz #founderinsight #biotechgrowth

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 30/07/2025

If your drug delivery platform is groundbreaking, why is your content invisible? Start by answering what only your tech can answer. #drugdelivery #biotechfounders #lifesciencestrategy

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 29/07/2025

Why do most 'innovative' biotech pitches still look like they were written for a 2004 VC deck? Innovation starts with how you tell the story. #biotechmarketing #founderbranding #lifescience

030

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 29/07/2025

Biotech founders avoid talking about failure. But your next partner might be more interested in your last mistake than your last milestone. What did you learn the hard way? #biotech #lifesciencefounder #sciencetalk

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 25/07/2025

Most founders ghost their audience between funding rounds. Then wonder why their next announcement gets ignored. In science, consistency builds credibility. Why forget that online? #StartupVisibility #FounderMarketing #LifeScienceGrowth

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 25/07/2025

[1/7] 🚨 Startups are now offering full-genome screening of embryos. It’s not science fiction. It’s a new reality in IVF, and it’s backed by serious money. But when tech moves faster than ethics, founders in life sciences need to pause and ask hard questions. Here’s what’s happening 👇

110

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 24/07/2025

LinkedIn is full of scientists trying to write like marketers. What if founders did the opposite? What would it look like if marketers started writing like scientists? #SciComm #LifeScienceBranding #ContentStrategy

030

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 24/07/2025

1/5 mRNA vaccines changed the game. But what if we could push them further, stronger immunity, lower doses, faster response? The secret may lie in cytokines. And scientists just found a way to harness them. 🧵

110

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 23/07/2025

Why are so many biotech websites still unreadable on mobile? You raised $30M, but your About page still says 'leveraging synergies' and takes 12 seconds to load. Who’s responsible for fixing this? #BiotechMarketing #UXfail #FoundersView

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 23/07/2025

1/7 What if we could switch off cancer-promoting genes, without changing the DNA itself? Not with brute force. But with surgical precision. CRISPR just got an upgrade. And it’s targeting epigenetic marks instead of sequences. 🧵

110

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 22/07/2025

AI won’t replace scientists. But founders who ignore AI will be replaced by those who don’t. What’s the most underrated AI tool in your stack right now? #AIinScience #LifeScienceFounders #BiotechFuture

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 22/07/2025

1/5 You’re more virus than you think. Roughly 8% of your DNA? Ancient viruses. Scientists used to call it junk. Turns out, it's helping regulate human gene expression right now. This flips the script. 🧵

110

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 21/07/2025

Most life science founders obsess over visibility. ↳ But what if visibility is the wrong KPI? ↳ What if memorability builds trust faster than reach ever could? ↳ What are you doing to be unforgettable? #LifeScience #BiotechBranding #FounderTips

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 21/07/2025

1/7 What's holding back next-gen mRNA therapeutics? Not the message. The delivery. But a forgotten molecule from the 60s just made a bold comeback—and it's rewriting the rules. This changes the game. Let’s break it down. 🧵

110

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 19/07/2025

Want a quick overview of biotech funding in Europe this week? 12 companies raised fresh capital, across all stages.

110

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 18/07/2025

New theory: The more complicated the molecule drawing, the less anyone in the room understands what it does. Show me a figure that made you instantly question your career choices. #MolConfusion #PosterSessionSurvivor #BiochemPain

020

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 18/07/2025

If lab‑grown meat becomes cheaper than plants, will steak be the new salad? Predict the cultural reset in one word. #AltProtein #FoodTech #CulturalShift

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 17/07/2025

AI protein design could spawn 'impossible' enzymes that eat plastic faster than we produce it. What's the unintended side‑effect we aren't seeing? #ProteinDesign #AIinBiotech #Biodegradation

110

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 17/07/2025

Reminder: a PhD doesn’t come with a free pass to use 17 words when 5 will do. Just saw someone write 'utilisation of facilitative frameworks' instead of 'using tools.' What’s the most aggressively overengineered sentence you’ve seen in a paper? #TooManyWords #PhDJargon #ScienceWriting

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 16/07/2025

Why do biotech logos either look like a toothpaste brand or a 1998 consulting firm? I swear I’ve seen the same abstract helix on 12 different pitch decks. Who’s got the worst offender? Drop a screenshot. #BiotechBranding #HelixOverload #ScienceDesignFails

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 16/07/2025

Startups race to patent human scent receptors to design 'digital smells'. Should our noses be proprietary code? Argue your stance. #Biotech #DigitalScent #IPinBiology

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 15/07/2025

Your morning coffee might soon contain engineered probiotics that tweak your mood in real time. Would you drink emotions on tap? #SyntheticBiology #Neurotech #FutureOfHealth

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 15/07/2025

Life science startup math: • 1 published paper = 3 months of LinkedIn posts • 1 conference selfie = 2 new investors • 1 preprint = 87 Slack messages arguing over whether to post it What’s your favourite fake metric? #StartupScience #MetricsMadness #FoundersInTheWild

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 14/07/2025

If Watson and Crick were on Bluesky today, they’d be arguing about who owns the IP rights to a meme. Modern scientists, what's the weirdest 'collaboration agreement' you've had to sign? No NDAs needed. Just vibes. #ScienceLife #IPDrama #AcademicTwitterButWeirder

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 14/07/2025

CRISPR could let us delete cancer mutations like typos. Who controls the 'spell‑check'? Drop the ethical blind spot everyone's ignoring. #GeneEditing #CancerResearch #Bioethics

010

Sébastien Simoncelli @ssimoncellimwtc.bsky.social · 11/07/2025

A founder who tells a boring story about a fascinating technology is still losing. #pitchsmarter #founderbranding #biotechstory

020